MedTrace Logo

Multidimensional Measurement of Psychopharmacological Treatment Response

NCT01184235 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2014-01-06

No results posted yet for this study

Summary

The study examines actigraphic, observational, psychometric and associated repeated measurements obtained prior to and during psychopharmacological treatment.

Conditions

  • Autism Spectrum Disorders
  • Mood Disorders
  • Sleep Disorders
  • Attention Deficit Disorders

Interventions

DRUG

Pharmacological Intervention

This study will include those anticipating or receiving any pharmacological intervention

Sponsors & Collaborators

  • Child Psychopharmacology Institute

    lead OTHER

Principal Investigators

  • Bill J Duke, M.A., Ph.D. · Child Psychopharmacology Institute

  • Robert D Staton, Ph.D., M.D. · Child Psychopharmacology Institute

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01184235 on ClinicalTrials.gov